Prognostic factors in breast cancer: current and new predictors of metastasis
- PMID: 12013528
- DOI: 10.1023/a:1014778713034
Prognostic factors in breast cancer: current and new predictors of metastasis
Abstract
Decisions regarding the use of adjuvant therapy for breast cancer are strongly influenced by the risk of disease recurrence and death. These risks are now determined by examining the currently recognized breast cancer prognostic factors, including clinical stage, axillary nodal status, tumor size and grade, hormone receptor status, and presence of lymphovascular involvement. Newer factors are being evaluated in an attempt to more precisely define disease-related prognosis. This paper provides an overview of issues that need to be considered when analyzing studies of prognostic factors as well as a review of the currently recognized and the newer candidate prognostic factors.
Similar articles
-
New prognostic factors for breast cancer recurrence.Semin Oncol. 2001 Feb;28(1):53-67. doi: 10.1016/s0093-7754(01)90045-4. Semin Oncol. 2001. PMID: 11254867 Review.
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients.Int J Cancer. 2009 Feb 15;124(4):896-904. doi: 10.1002/ijc.24001. Int J Cancer. 2009. PMID: 19035452
-
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.Breast Cancer Res. 2017 Nov 14;19(1):120. doi: 10.1186/s13058-017-0911-9. Breast Cancer Res. 2017. PMID: 29137653 Free PMC article.
-
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.Breast Cancer. 2016 Nov;23(6):830-843. doi: 10.1007/s12282-015-0649-0. Epub 2015 Oct 14. Breast Cancer. 2016. PMID: 26467036
Cited by
-
EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis.Breast Cancer Res Treat. 2013 Apr;138(3):741-52. doi: 10.1007/s10549-013-2498-x. Epub 2013 Mar 29. Breast Cancer Res Treat. 2013. PMID: 23539298 Free PMC article.
-
p27 deregulation in breast cancer: prognostic significance and implications for therapy.J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):67-80. doi: 10.1023/B:JOMG.0000023589.00994.5e. J Mammary Gland Biol Neoplasia. 2004. PMID: 15082919 Review.
-
Biological characterisation of breast cancer by means of PET.Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S80-7. doi: 10.1007/s00259-004-1529-6. Epub 2004 May 4. Eur J Nucl Med Mol Imaging. 2004. PMID: 15127240 Review.
-
Positively biased appraisals in everyday life: when do they benefit mental health and when do they harm it?J Pers Soc Psychol. 2011 Sep;101(3):415-432. doi: 10.1037/a0023332. J Pers Soc Psychol. 2011. PMID: 21500926 Free PMC article.
-
Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer.BMC Med. 2021 Nov 18;19(1):273. doi: 10.1186/s12916-021-02146-7. BMC Med. 2021. PMID: 34789257 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical